Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990)
Hong Kong · Delayed Price · Currency is HKD 429.60
+12.80 (3.07%)
Last updated: Jan 23, 2026, 9:30 AM HKT
HKG:6990 Market Cap
HKG:6990 has a market cap or net worth of 96.12 billion as of January 26, 2026. Its market cap has increased by 159.47% in one year.
Market Cap
96.12B
Enterprise Value
91.32B
Revenue
1.64B
Ranking
n/a
PE Ratio
n/a
Stock Price
429.60
Market Cap Chart
Since July 11, 2023, HKG:6990's market cap has increased from 13.49B to 96.12B, an increase of 612.56%. That is a compound annual growth rate of 116.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 26, 2026 | 96.12B | 5.10% |
| Dec 31, 2025 | 91.46B | 146.43% |
| Dec 31, 2024 | 37.11B | 64.54% |
| Dec 29, 2023 | 22.56B | 67.21% |
| Jul 11, 2023 | 13.49B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 292.81B |
| WuXi Biologics | 162.53B |
| Innovent Biologics | 145.19B |
| Sino Biopharmaceutical | 118.52B |
| Akeso | 107.31B |
| 3SBio | 60.84B |
| RemeGen | 58.79B |
| Shanghai Junshi Biosciences | 37.04B |